Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Operating Expenses | 18,791 | 17,322 | 13,832 | 12,664 | 15,209 |
| Operating Income | -18,791 | -17,322 | -13,832 | -12,664 | -15,209 |
| Interest Expense | 0 | 216 | 214 | 209 | 204 |
| Other Income | -220 | 0 | 2 | 0 | 0 |
| Pre-tax Income | -19,011 | -17,538 | -14,044 | -12,873 | -15,413 |
| Net Income Continuous | -19,011 | -17,538 | -14,044 | -12,873 | -15,413 |
| Net Income | $-19,011 | $-17,538 | $-14,044 | $-12,873 | $-15,413 |
| EPS Basic Total Ops | -0.78 | -0.74 | -0.72 | -0.84 | -1.01 |
| EPS Basic Continuous Ops | -0.78 | -0.74 | -0.73 | -0.84 | -1.01 |
| EPS Diluted Total Ops | -0.78 | -0.74 | -0.72 | -0.84 | -1.01 |
| EPS Diluted Continuous Ops | -0.78 | -0.74 | -0.73 | -0.84 | -1.01 |
| EBITDA(a) | $-18,524 | $-17,069 | $-13,599 | $-12,441 | $-14,999 |